Shareholder plans sale of 1,000 UTHR shares

A shareholder has filed a notice of proposed sale under Rule 144 for 1,000 shares of common stock of the issuer, to be sold through Morgan Stanley Smith Barney LLC on or about 01/06/2026 on the NASDAQ.

Accepted by SEC EDGAR 01/06/2026 - 04:07 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

A shareholder has filed a notice of proposed sale under Rule 144 for 1,000 shares of common stock of the issuer, to be sold through Morgan Stanley Smith Barney LLC on or about 01/06/2026 on the NASDAQ. The filing lists an aggregate market value of 510000.00 for these shares and notes that 43056599 shares of the issuer’s common stock were outstanding.

The 1,000 shares to be sold were acquired on 01/06/2026 via a stock option exercise from the issuer, paid in cash. The notice also reports that the same seller disposed of an additional 1,000 common shares on 01/02/2026 for 500014.60 in gross proceeds during the past three months. By signing, the seller represents that they are not aware of any undisclosed material adverse information about the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Rule 144 notice for UTHR disclose?

The notice discloses that a shareholder plans to sell 1,000 shares of common stock of the issuer on or about 01/06/2026 on the NASDAQ, with an aggregate market value of 510000.00.

How many UTHR shares are planned to be sold and through which broker?

The filing states that 1,000 common shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, NY 10004.

How and when were the UTHR shares to be sold acquired?

According to the filing, the 1,000 shares to be sold were acquired on 01/06/2026 via a stock option exercise from the issuer, with the purchase price paid in cash on the same date.

What prior UTHR share sales by this seller are reported?

The notice reports that the same seller, listed as CHRISTOPHER CAUSEY, sold 1,000 common shares on 01/02/2026, generating 500014.60 in gross proceeds during the past three months.

How many UTHR shares are reported as outstanding in this filing?

The document states that there were 43056599 shares of the issuer’s common stock outstanding.

What representation does the seller make about information on the issuer?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001237334
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	UNITED THERAPEUTICS CORPORATION
SEC File Number	000-26301
Address of Issuer	1000 SPRING STREET SILVER SPRING MARYLAND 20910
Phone	(301) 608-9292
Name of Person for Whose Account the Securities are To Be Sold	CHRISTOPHER CAUSEY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1000	510000.00	43056599	01/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/06/2026	Stock Option Exercise	Issuer			1000	01/06/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
CHRISTOPHER CAUSEY 1000 SPRING STREET SILVER SPRING MD 20910	Common	01/02/2026	1000	500014.60

144: Remarks and Signature

Remarks
Date of Notice	01/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/30/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Christopher Causey
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)